Neostigmine Methylsulfate Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Jan 12, 2026 · last update Jan 12, 2026
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jan 12, 2026 Updated Jan 12, 2026 Discontinued Jan 12, 2026 |